CEPI, the global outbreak preparedness group, has been busy since it launched last year, raising more than $600 million and handing out grants to back research into
Aiming to challenge flu shot market leader Sanofi, Vaxart put up phase 2 data for an oral flu vaccine candidate that the biotech says provided participants both mucosal
Johnson & Johnson has already advanced a “mosaic” HIV vaccine candidate into efficacy testing in five southern African countries, but this week the company unveiled initial